Perea, Juan R. http://orcid.org/0000-0001-7607-8814
Bolós, Marta http://orcid.org/0000-0003-2652-8607
Cuadros, Raquel
García, Esther
García-Escudero, Vega http://orcid.org/0000-0003-1762-0882
Hernández, Félix http://orcid.org/0000-0001-8753-8249
McManus, Róisín M. http://orcid.org/0000-0002-6896-0302
Heneka, Michael T. http://orcid.org/0000-0003-4996-1630
Avila, Jesús http://orcid.org/0000-0002-6288-0571
Funding for this research was provided by:
Centro de Biología Molecular Severo Ochoa
Article History
Received: 26 August 2021
Accepted: 21 December 2021
First Online: 10 January 2022
Declarations
:
: Animal housing and maintenance protocols followed the guidelines of the Council of Europe Convention ETS123, revised as indicated in Directive 86/609/EEC. Animal experiments were performed under protocols (P15/P16/P18/P22) approved by the Institutional Animal Care and Utilization Committee (PROEX 291/15) and following ARRIVE guidelines.
: Not applicable.
: Not applicable.
: M. T. H. is a clinical advisory board member at IFM Therapeutics, scientific advisory board member at Alector, associate editor of Neurology and Neuroinflammation, and honoraria for oral presentations from Pfizer, Novartis, Roche, Abbvie, and Biogen.